Lumateperone 42 mg — clinical trials using this drug

Public-registry trials using Lumateperone 42 mg that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
Lumateperone for the Prevention of Relapse in Patients With Schizophrenia	Intra-Cellular Therapies, Inc.	Schizophrenia	PHASE3	43

Registry history

First registered study	December 2011 — NCT01499563 (Intra-Cellular Therapies, Inc.)
Registered studies matching this name	23 all-time · 7 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Trialed alongside

Placebo

Other Schizophrenia drugs

← Eichor home · All tracked trials · Schizophrenia studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →